HK2 and breast cancer: Accordingly, our study found that circKIF4A is biologically active in BC and revealed the precise role of the circKIF4A-miR-335-ALDOA/OCT4-HK2/PKM2 axis in the metabolic reprogramming during the development of breast cancer and liver metastasis.